Publications

5674 Results

Design and analysis for survival data under order restrictions with a modified logrank test.

Authors
PY Liu;WY Tsai;M Wolf
Journal / Conference
Statistics in Medicine 17:1469-1479
Year
1998
Research Committee(s)
Multiple sites

EBV DNA quantitation in serum is highly correlated with the development and regression of post-transplant lymphoproliferative disorder (PTLD) in solid organ tranplant recipients.

Authors
LJ Swinnen;ML Gulley;E Hamilton;SA Schichman
Journal / Conference
Blood 92(10)(Suppl.1):314a-315a(#1291)
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9239

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: An intergroup study.

Authors
JH Fetting;R Gray;DL Fairclough;TJ Smith;KA Margolin;ML Citron;M Grove-Conrad;D Cella;K Pandya;N Robert;IC Henderson;CK Osborne;MD Abeloff
Journal / Conference
Journal of Clinical Oncology 16(7):2382-2391
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8931 (INT-0108) (EST-3189)

Benefit of cycloporine (CsA) modulation of anthracycline resistance in high-risk AML: A Southwest Oncology Group (SWOG) study.

Authors
AF List;KJ Kopecky;CL Willman;C Spier;R Dorr;L Flaherty;H Hynes;F Appelbaum
Journal / Conference
Blood 92(10)(Suppl.1):312a(#1281)
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9126

Alternate day oral prednisone maintenance therapy improves progression-free and overall survival in multiple myeloma patients.

Authors
J Berenson;J Crowley;B Barlogie;S Salmon
Journal / Conference
Blood 92(10(Suppl.1):318a(#1305)
Year
1998
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9210

Karyotypic analysis predicts outcome of pre-and post- remission therapy in adult acute myeloid leukemia (AML): A SWOG/ECOG intergroup study.

Authors
ML Slovak;KJ Kopecky;PA Cassileth;DH Harrington;K Theil;A Mohamed;A Chung;E Paietta;C Willman;DR Head;SJ Forman;FR Appelbaum
Journal / Conference
Blood 92(10)(Suppl.1):678a(#2795)
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9034 (EST-3489) (CALGB-9120)

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

Authors
PA Cassileth;DP Harrington;FR Appelbaum;HM Lazarus;JM Rowe;E Paietta;C Willman;DD Hurd;JM Bennett;KG Blume;DR Head;PH Wiernik
Journal / Conference
New England Journal of Medicine 339(23):1649-1656
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9034 (EST-3489) (CALGB-9120)

Letter-to-the-editor: an open letter to the American Society of Clinical Oncology

Authors
SJ Green;JJ Crowley;BA Blumenstein;JK Benedetti
Journal / Conference
Journal of Clinical Oncology 16(10):3478-3480
Year
1998
Research Committee(s)
Multiple sites

A phase I dose-finding study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone (M), etoposide (E), and the MDR modulator PSC833: Southwest Oncology Group study #9617.

Authors
TR Chauncey;C Rankin;JE Anderson;JE Godwin;M Kalaycio;DF Moore;SH Petersdorf;MS Shurafa;EH Kraut;DR Head;ML Slovak;CL Willman;FR Appelbaum
Journal / Conference
Blood 92(10)(Suppl.1):231a(#945)
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
S9617

Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection.

Authors
RM Goldberg;TR Fleming;CM Tangen;CG Moertel;JS Macdonald;DG Haller;JA Laurie
Journal / Conference
Annals of Internal Medicine 129(1):27-35
Year
1998
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)